Rubis B - Search Results

1

The tetramethoxyflavone zapotin selectively activates protein kinase C epsilon, leading to its down-modulation accompanied by Bcl-2, c-Jun and c-Fos decrease.

Toton E, Lisiak N, Rubis B, Budzianowski J, Gruber P, Hofmann J, Rybczynska M. Toton E, et al. Among authors: rubis b. Eur J Pharmacol. 2012 May 5;682(1-3):21-8. doi: 10.1016/j.ejphar.2012.02.020. Epub 2012 Feb 21. Eur J Pharmacol. 2012. PMID: 22381066 Free PMC article.

2

Spectroscopic study and G-quadruplex DNA binding affinity of two bioactive papaverine-derived ligands.

Galezowska E, Masternak A, Rubis B, Czyrski A, Rybczyńska M, Hermann TW, Juskowiak B. Galezowska E, et al. Among authors: rubis b. Int J Biol Macromol. 2007 Dec 1;41(5):558-63. doi: 10.1016/j.ijbiomac.2007.07.008. Epub 2007 Jul 21. Int J Biol Macromol. 2007. PMID: 17719085

3

Beneficial or harmful influence of phytosterols on human cells?

Rubis B, Paszel A, Kaczmarek M, Rudzinska M, Jelen H, Rybczynska M. Rubis B, et al. Br J Nutr. 2008 Dec;100(6):1183-91. doi: 10.1017/S0007114508981423. Epub 2008 Apr 29. Br J Nutr. 2008. PMID: 18445305

4

The biological activity of G-quadruplex DNA binding papaverine-derived ligand in breast cancer cells.

Rubis B, Kaczmarek M, Szymanowska N, Galezowska E, Czyrski A, Juskowiak B, Hermann T, Rybczynska M. Rubis B, et al. Invest New Drugs. 2009 Aug;27(4):289-96. doi: 10.1007/s10637-008-9173-9. Epub 2008 Sep 5. Invest New Drugs. 2009. PMID: 18773143

5

[siRNA targeting telomerase--effective tool in anti-cancer therapy?].

Rubiś B, Półrolniczak A, Rybczyńska M. Rubiś B, et al. Postepy Biochem. 2008;54(4):384-92. Postepy Biochem. 2008. PMID: 19248585 Review. Polish.

6

CXCL12-3' G801A polymorphism is not a risk factor for breast cancer.

Kruszyna Ł, Lianeri M, Rubis B, Knuła H, Rybczyńska M, Grodecka-Gazdecka S, Jagodziński PP. Kruszyna Ł, et al. Among authors: rubis b. DNA Cell Biol. 2010 Aug;29(8):423-7. doi: 10.1089/dna.2010.1030. DNA Cell Biol. 2010. PMID: 20406099

7

CCL2 -2518 A/G single nucleotide polymorphism as a risk factor for breast cancer.

Kruszyna L, Lianeri M, Rubis B, Knuła H, Rybczyńska M, Grodecka-Gazdecka S, Jagodziński PP. Kruszyna L, et al. Among authors: rubis b. Mol Biol Rep. 2011 Feb;38(2):1263-7. doi: 10.1007/s11033-010-0225-9. Epub 2010 Jun 20. Mol Biol Rep. 2011. PMID: 20563852

8

Phytosterols in physiological concentrations target multidrug resistant cancer cells.

Rubis B, Polrolniczak A, Knula H, Potapinska O, Kaczmarek M, Rybczynska M. Rubis B, et al. Med Chem. 2010 Jul;6(4):184-90. doi: 10.2174/1573406411006040184. Med Chem. 2010. PMID: 20843282

9

Biopharmaceutical characterization of some new papaverine decomposition products.

Czyrski A, Hermann T, Rubiś B, Rybczyńska M, Sledź D. Czyrski A, et al. Among authors: rubis b. Pharmazie. 2011 Mar;66(3):165-7. Pharmazie. 2011. PMID: 21553644

10

Oleanolic acid derivative methyl 3,11-dioxoolean-12-en-28-olate targets multidrug resistance related to ABCB1.

Paszel A, Rubiś B, Bednarczyk-Cwynar B, Zaprutko L, Kaczmarek M, Hofmann J, Rybczyńska M. Paszel A, et al. Among authors: rubis b. Pharmacol Rep. 2011;63(6):1500-17. doi: 10.1016/s1734-1140(11)70714-9. Pharmacol Rep. 2011. PMID: 22358098 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page